Patents by Inventor Lisa Koetzner

Lisa Koetzner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240382468
    Abstract: Substituted tetrazole derivatives are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.
    Type: Application
    Filed: March 16, 2021
    Publication date: November 21, 2024
    Applicants: Merck Patent GmbH, RYVU THERAPEUTICS S.A.
    Inventors: Thomas Fuchss, Lisa Koetzner, Christina Schindler, Daniel Kuhn
  • Publication number: 20240317753
    Abstract: Tricyclic heterocycles are disclosed. These heterocyclic compounds are useful as TEAD binders and/or inhibitors of YAP-TEAD and TAZ-TEAD protein-protein interaction or binding and for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases, in particular cancer.
    Type: Application
    Filed: May 5, 2021
    Publication date: September 26, 2024
    Applicants: Merck Patent GmbH, Cancer Research Technology Ltd.
    Inventors: Timo HEINRICH, Sarah Schlesiger, Jakub Gunera, Emma Carswell, Lisa Koetzner, Andreas Blum
  • Publication number: 20240270748
    Abstract: Tricyclic heterocycles are useful as TEAD binders and/or inhibitors of YAP-TEAD. Tricyclic heterocycles can be used for TAZ-TEAD protein-protein interaction or binding and for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases, in particular cancer.
    Type: Application
    Filed: November 2, 2021
    Publication date: August 15, 2024
    Applicants: Merck Patent GmbH, Cancer Research Technology Ltd.
    Inventors: Timo Heinrich, Sarah Schlesiger, Jakub Gunera, Lisa Koetzner, Emma Carswell, Andreas Blum
  • Publication number: 20240009175
    Abstract: Substituted tetrazole derivatives are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.
    Type: Application
    Filed: March 16, 2021
    Publication date: January 11, 2024
    Applicants: Merck Patent GmbH, RYVU THERAPEUTICS S.A.
    Inventors: Thomas FUCHSS, Lisa Koetzner, Christina Schindler, Daniel Kuhn
  • Publication number: 20230278958
    Abstract: The tricyclic heterocycles disclosed herein are useful as TEAD binders and/or inhibitors of YAP-TEAD and TAZ-TEAD protein-protein interaction or binding and for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases, in particular cancer.
    Type: Application
    Filed: July 20, 2021
    Publication date: September 7, 2023
    Applicants: Merck Patent GmbH, Cancer Research Technology Ltd.
    Inventors: Timo Heinrich, Sarah Schlesiger, Jakub Gunera, Lisa Koetzner, Emma Carswell, Andreas Blum
  • Publication number: 20230271956
    Abstract: Substituted amide derivatives are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.
    Type: Application
    Filed: March 16, 2021
    Publication date: August 31, 2023
    Applicants: Merck Patent GmbH, RYVU THERAPEUTICS S.A.
    Inventors: Lisa Koetzner, Thomas Fuchss, Christina Schindler, Daniel Kuhn
  • Publication number: 20230174538
    Abstract: Tricyclic heterocycles are disclosed. These heterocyclic compounds are useful as TEAD binders and/or inhibitors of YAP-TEAD and TAZ-TEAD protein-protein interaction or binding and for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases, in particular cancer.
    Type: Application
    Filed: May 5, 2021
    Publication date: June 8, 2023
    Applicants: Merck Patent GmbH, Cancer Research Technology Ltd.
    Inventors: Timo HEINRICH, Sarah Schlesiger, Jakub Gunera, Emma Carswell, Lisa Koetzner, Andreas Blum
  • Publication number: 20230149371
    Abstract: Substituted tetrazole derivatives are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.
    Type: Application
    Filed: March 16, 2021
    Publication date: May 18, 2023
    Applicants: Merck Patent GmbH, RYVU THERAPEUTICS S.A.
    Inventors: Thomas FUCHSS, Lisa Koetzner, Christina Schindler, Daniel Kuhn